CI · Cigna Group · Documents

Oct 31

Current report 8-K

Financial results

Oct 31

Quarterly report 10-Q FY2024 Q3, ended Sep 30

Quarterly report for FY2024 Q3

Revenue $63.69B ▲ 29.9% Net income $825M ▼ 43.1% Diluted EPS $2.63 ▼ 44.5%

Oct 31

Earnings call

Q3 2024 earnings call

Sep 3

Current report 8-K

Regulation FD disclosure

Aug 1

Current report 8-K

Financial results

Aug 1

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $60.52B ▲ 24.6% Net income $1.63B ▲ 7.9% Diluted EPS $5.45 ▲ 10.8%

Aug 1

Earnings call

Q2 2024 earnings call

Jun 20

Current report 8-K Events of Jun 14

Director or officer change, or executive pay

Jun 6

Current report 8-K

Regulation FD disclosure

May 2

Current report 8-K

Financial results

May 2

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $57.26B ▲ 23.1% Net loss $212M Diluted EPS -$0.97

May 2

Earnings call

Q1 2024 earnings call

Apr 26

Current report 8-K Events of Apr 25

Entered into a material agreement, New debt or off-balance-sheet obligation, Other events

Apr 26

Current report 8-K Events of Apr 24

Shareholder vote results

Apr 12

Proxy statement DEFA14A

Proxy statement

Apr 5

Proxy statement DEFA14A

Proxy statement

Mar 15

Proxy statement DEF 14A Meeting Apr 24, 2024

Proxy statement

Mar 15

Proxy statement DEFA14A

Proxy statement

Mar 15

Annual report to holders ARS

Annual report to holders

Mar 7

Current report 8-K

Regulation FD disclosure

Feb 29

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $195.27B ▲ 8.2% Net income $5.37B ▼ 20.8% Diluted EPS $17.39 ▼ 18.8%

Feb 15

Current report 8-K Events of Feb 14

Other events

Feb 13

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation, Regulation FD disclosure, Other events

Feb 7

Current report 8-K Events of Feb 5

Other events

Feb 2

Current report 8-K

Financial results

Feb 2

Earnings call

Q4 2023 earnings call

Jan 31

Current report 8-K

Other events

Jan 22

Current report 8-K Events of Jan 16

Director or officer change, or executive pay

Jan 17

Current report 8-K Events of Jan 16

Director or officer change, or executive pay

Dec 29

Current report 8-K

Regulation FD disclosure

Dec 11

Current report 8-K Events of Dec 10

Regulation FD disclosure

Dec 4

Current report 8-K

Regulation FD disclosure

Nov 2

Current report 8-K

Financial results

Nov 2

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $49.05B ▲ 8.3% Net income $1.45B ▼ 47.8% Diluted EPS $4.74 ▼ 47.2%

Nov 2

Earnings call

Q3 2023 earnings call

Sep 15

Current report 8-K Events of Sep 14

Director or officer change, or executive pay

Sep 11

Current report 8-K

Regulation FD disclosure

Aug 3

Current report 8-K

Financial results

Aug 3

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $48.59B ▲ 6.8% Net income $1.51B ▼ 3.8% Diluted EPS $4.92 ▲ 0.6%

Aug 3

Earnings call

Q2 2023 earnings call

Jun 5

Current report 8-K

Regulation FD disclosure

May 5

Current report 8-K

Financial results

May 5

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $46.52B ▲ 5.7% Net income $1.31B ▲ 7.8% Diluted EPS $4.24 ▲ 13.7%

May 5

Earnings call

Q1 2023 earnings call

May 1

Current report 8-K Events of Apr 26

Director or officer change, or executive pay

Apr 28

Current report 8-K Events of Apr 27

Entered into a material agreement, New debt or off-balance-sheet obligation, Other events

Apr 27

Current report 8-K Events of Apr 26

Shareholder vote results

Apr 24

Proxy statement DEFA14A

Proxy statement

Apr 17

Proxy statement DEFA14A

Proxy statement

Apr 10

Proxy statement DEFA14A

Proxy statement